Core Scientific, Inc. (NASDAQ:CORZ – Get Free Report) insider Todd Duchene sold 10,000 shares of the company’s stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $18.67, for a total value of $186,700.00. Following the completion of the transaction, the insider directly owned 1,217,896 shares in the company, valued at approximately $22,738,118.32. This trade represents a 0.81% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Core Scientific Trading Down 4.0%
NASDAQ CORZ opened at $17.37 on Friday. The stock has a market cap of $5.58 billion, a PE ratio of -3.93 and a beta of 5.48. Core Scientific, Inc. has a twelve month low of $13.35 and a twelve month high of $30.46. The stock has a fifty day simple moving average of $20.24 and a 200-day simple moving average of $21.02.
Core Scientific (NASDAQ:CORZ – Get Free Report) last issued its quarterly earnings data on Tuesday, July 28th. The company reported ($3.32) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.06) by ($3.26). The company had revenue of $164.20 million during the quarter, compared to analysts’ expectations of $144.83 million. Research analysts predict that Core Scientific, Inc. will post -1.36 EPS for the current year.
Hedge Funds Weigh In On Core Scientific
Analysts Set New Price Targets
A number of research firms have recently issued reports on CORZ. B. Riley Financial boosted their price target on shares of Core Scientific from $33.00 to $42.00 and gave the company a “buy” rating in a research note on Monday, August 3rd. Jefferies Financial Group increased their price objective on shares of Core Scientific from $24.00 to $37.00 and gave the stock a “buy” rating in a research report on Thursday, May 14th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Core Scientific in a report on Friday, July 17th. Wolfe Research reiterated a “buy” rating on shares of Core Scientific in a report on Wednesday, July 29th. Finally, Needham & Company LLC boosted their target price on Core Scientific from $29.00 to $35.00 and gave the company a “buy” rating in a research report on Wednesday, July 29th. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Core Scientific presently has an average rating of “Moderate Buy” and an average target price of $32.18.
Check Out Our Latest Stock Report on Core Scientific
Core Scientific Company Profile
Core Scientific, Inc (NASDAQ: CORZ) is a digital infrastructure company that develops and operates data centers for high-performance computing. Its business has historically centered on large-scale bitcoin mining, including the deployment and operation of specialized computing equipment and supporting power, networking and facility infrastructure.
The company also provides hosting and colocation services for digital asset miners and other high-performance computing customers. Core Scientific has increasingly focused on expanding its data center platform for artificial intelligence and other compute-intensive workloads, including infrastructure designed to support graphics processing unit (GPU) deployments.
Founded in 2017, Core Scientific operates data center facilities in the United States and emerged from Chapter 11 bankruptcy protection in January 2024.
Featured Articles
- Five stocks we like better than Core Scientific
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
- Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle
Receive News & Ratings for Core Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
